The startup has partnered with Eli Lilly and enjoys the backing of some of Silicon Valley's most influential VCs.

"FDA and EMA release collaborative AI framework for drug development" was originally created and published by Pharmaceutical ...

The collaboration marks a turning point in AI-driven drug design and trial forecasting, de-risking the drug development ...

The U.S. Food and Drug Administration and the European Medicines Agency jointly issued principles for safe and responsible ...

Accelerated drug discovery and development platform Converge Bio Inc. today announced it has raised $25 million in ...

In Darwinian terms, survival isn’t a matter of being the biggest, the fastest, or the strongest of the species, but instead ...

Millions of people live with atrial fibrillation, a racing, uneven heartbeat that can leave you exhausted and scared. Yet it ...

Persist AI is a drug formulation technology company that developed artificial intelligence-powered Cloud Lab, a remote, cloud ...

Top of the list is that AIs must be human-centric by design and align with ethical values. They must be developed using a ...

FDA and EMA have issued 10 guiding principles for AI in drug development with the intended goal of ensuring safety and ...

AI and machine learning are revolutionizing drug discovery, development, and lifecycle management, addressing industry ...

Loyal’s application for drug approval is another step closer to potential approval through the FDA Center for Veterinary ...